COMMODORE CAPITAL LP
CIK 1831942 · last filed 2024-01-12
COMMODORE CAPITAL LP is a corporate insider who has filed 18 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing shows the insider sold $18.9M of VERA on Jan 12, 2024. Across all open-market trades the lifetime net is +$6.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $176.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$176.31M
4
18
$6.38M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VERA | 10%+ Owner | 4,400,000 | $34.26 | $150.74M | -$12.10M | 2 | 2024-01-12 |
| VTGN | 10%+ Owner | 1,575,000 | $0.58 | $907.5K | $17.96M | 2 | 2023-10-06 |
| IMRA | 10%+ Owner | 1,448,640 | $17.02 | $24.65M | $177.2K | 2 | 2023-02-27 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | 10%+ Owner | 461,286 | $1.10 | $507.4K | $340.0K | 12 | 2022-11-16 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-12 | VERA | Sell (S) | −1,050,000 | -$18.90M | EDGAR |
| 2023-10-06 | VTGN | Grant (A) | — | $0 | EDGAR |
| 2023-08-09 | VTGN | Buy (P) | +775,756 | $17.96M | EDGAR |
| 2023-06-22 | VERA | Buy (P) | +448,217 | $6.80M | EDGAR |
| 2023-02-27 | IMRA | Mixed | +730,512 | $13.7K | EDGAR |
| 2023-02-23 | IMRA | Buy (P) | +31,759 | $163.5K | EDGAR |
| 2022-11-16 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Sell (S) | −3,250,000 | -$2.29M | EDGAR |
| 2021-11-29 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +2,922 | $15.8K | EDGAR |
| 2021-11-23 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +13,204 | $72.3K | EDGAR |
| 2021-11-12 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +17,563 | $104.3K | EDGAR |